Guangdong Zhongsheng Pharmaceutical Co Ltd Asset Resilience Ratio
Guangdong Zhongsheng Pharmaceutical Co Ltd asset resilience ratio. Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has an Asset Resilience Ratio of 6.62% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Guangdong Zhongsheng Pharmaceutical Co L defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Guangdong Zhongsheng Pharmaceutical Co Ltd (2014–2024)
Asset resilience ratio of Guangdong Zhongsheng Pharmaceutical Co Ltd from 2014 to 2024. This chart shows how Guangdong Zhongsheng Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Guangdong Zhongsheng Pharmaceutical Co L debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Guangdong Zhongsheng Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Guangdong Zhongsheng Pharmaceutical Co L.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥342.12 Million | 6.62% |
| Total Liquid Assets | CN¥342.12 Million | 6.62% |
Asset Resilience Insights
- Limited Liquidity: Guangdong Zhongsheng Pharmaceutical Co Ltd maintains only 6.62% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Guangdong Zhongsheng Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Guangdong Zhongsheng Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
H Lundbeck A/S
CO:HLUN-B |
Drug Manufacturers - Specialty & Generic | -0.56% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Viyash Scientific Limited
NSE:SEQUENT |
Drug Manufacturers - Specialty & Generic | 0.08% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
Guangdong Zhongsheng Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2014–2024)
Guangdong Zhongsheng Pharmaceutical Co Ltd asset resilience ratio by year from 2014 to 2024. The table below shows the annual Asset Resilience Ratio data for Guangdong Zhongsheng Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 5.51% | CN¥305.99 Million ≈ $44.78 Million |
CN¥5.55 Billion ≈ $812.65 Million |
-5.07pp |
| 2023-12-31 | 10.58% | CN¥683.06 Million ≈ $99.95 Million |
CN¥6.46 Billion ≈ $945.08 Million |
+4.68pp |
| 2022-12-31 | 5.90% | CN¥340.68 Million ≈ $49.85 Million |
CN¥5.78 Billion ≈ $845.11 Million |
+1.00pp |
| 2021-12-31 | 4.89% | CN¥239.92 Million ≈ $35.11 Million |
CN¥4.90 Billion ≈ $717.31 Million |
-1.53pp |
| 2020-12-31 | 6.42% | CN¥306.65 Million ≈ $44.87 Million |
CN¥4.78 Billion ≈ $698.89 Million |
+6.04pp |
| 2018-12-31 | 0.38% | CN¥20.00 Million ≈ $2.93 Million |
CN¥5.24 Billion ≈ $767.41 Million |
-5.78pp |
| 2017-12-31 | 6.16% | CN¥299.00 Million ≈ $43.75 Million |
CN¥4.86 Billion ≈ $710.60 Million |
-- |
| 2016-12-31 | 0.00% | CN¥0.00 ≈ $0.00 |
CN¥4.23 Billion ≈ $618.31 Million |
-- |
| 2015-12-31 | 5.55% | CN¥185.00 Million ≈ $27.07 Million |
CN¥3.33 Billion ≈ $487.87 Million |
-15.70pp |
| 2014-12-31 | 21.25% | CN¥490.00 Million ≈ $71.70 Million |
CN¥2.31 Billion ≈ $337.49 Million |
-- |
About Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangdong Zhongsheng Pharmaceutical Co., Ltd. engages in research, development, production, and sale of pharmaceutical drugs in China. The company offers traditional Chinese medicine and chemical medicine. It also focuses on the fields of cardiovascular, respiratory, ophthalmology, and digestive. Guangdong Zhongsheng Pharmaceutical Co., Ltd. was founded in 1979 and is based in Dongguan, China.